The Track Of Pharmaceutical Intermediates Came From Medicine To Medicine

- Aug 06, 2019-

The impact of the impact of economic globalization on China's economy is far more profound than its philosophy that each production enterprise does not have to be large and should concentrate its funds and energy on other supporting materials and conditions in the industries and fields that it is good at. Under the influence of this concept, the pharmaceutical industry can transfer some of the processing of primary products such as solvent recovery to the cooperative enterprises, and gradually reduce some pollution and Hazardous products are handed over to chemical plants for production. For example, phenylacetic acid chloroacetic acid used in the production of penicillin has been in the vicinity of Shijiazhuang. Since the 1970s, a large number of small township enterprises and individual enterprises have been produced for the production of phenylacetic acid and chloroacetic acid in North China Pharmaceutical.

As the cooperation between the two parties continues to deepen, pharmaceutical companies are gradually transferring some of the more technically expensive products with higher added value to the chemical plant. For example, arsenic acid AE-active ester triazine ring tetrazolium acetate is used for the production of cephalosporin antibiotics. Products such as phenylglycine (Deng potash) HO-EPCP have enabled the branch industry to develop rapidly in the 1990s. A number of pharmaceutical intermediates with an output value of tens of millions to 100 million yuan, such as Zhejiang Yongning Pharmaceutical Factory Fushun Meiqiang Pharmaceutical Factory Zhejiang Hengdian Debang Group Shandong Ruiying Group Shandong Jincheng Chemical Plant and many other companies have developed the industry to a closer cooperation with pharmaceutical companies. The raw materials (bacteria powder) are directly synthesized by manufacturers producing pharmaceutical intermediates. The products are sold in the form of chemical products to pharmaceutical companies for refining and then sold as pharmaceuticals. The pharmaceutical intermediates can further extend the product chain, increase the profit of the products and improve the stability of sales, while the pharmaceutical companies reduce the investment. Focus on the aseptic dispensing that you are good at. Because there is no medical product in the pharmaceutical intermediate industry. The production license pharmaceutical companies can not compete with the market and therefore the cooperation of a certain complementarity.